Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations
Oncology
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Taiho OncologyNJ - Princeton
2 programs2
Futibatinib and BinimetinibPhase 1Small Molecule1 trial
TAS-117Phase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Taiho OncologyFutibatinib and Binimetinib
Taiho OncologyTAS-117
Clinical Trials (2)
Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
Start: Sep 2021Est. completion: Sep 2023
Phase 1Terminated
TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations
Start: Mar 2021Est. completion: Mar 2023
Phase 1Terminated
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
3h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
3h ago
Office Administrator
SystImmune
3h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
3h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
3h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
3h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
Small Molecule is the dominant modality (100% of programs)
1 companies competing in this space